,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2021_Human,Cell cycle,0.04032258064516129,4.0632226170795786e-07,2.356669117906156e-05,0,0,41.71428571428572,613.8724027558424,PCNA;ORC6;CDC45;GADD45A;MYC
1,KEGG_2021_Human,Glutathione metabolism,0.05263157894736842,4.827884938581341e-05,0.0014000866321885,0,0,50.30555555555556,499.96261878789824,RRM2;ODC1;SRM
2,KEGG_2021_Human,Thyroid cancer,0.05405405405405406,0.0009725891624110714,0.0188033904732807,0,0,49.54037267080745,343.5896723752696,GADD45A;MYC
3,KEGG_2021_Human,Arginine and proline metabolism,0.04,0.0017712212130127,0.0256827075886846,0,0,36.09963768115942,228.73040961874747,ODC1;SRM
4,KEGG_2021_Human,Endometrial cancer,0.034482758620689655,0.0023754913784137,0.027555699989599,0,0,30.930124223602483,186.8968520281422,GADD45A;MYC
5,KEGG_2021_Human,p53 signaling pathway,0.0273972602739726,0.0037336095301643,0.0334721371425895,0,0,24.377219840783837,136.27791764114787,RRM2;GADD45A
6,KEGG_2021_Human,Chronic myeloid leukemia,0.02631578947368421,0.0040397406896228,0.0334721371425895,0,0,23.38542890716804,128.890540062766,GADD45A;MYC
7,KEGG_2021_Human,Colorectal cancer,0.023255813953488372,0.0051413941977667,0.0372751079338092,0,0,20.591097308488614,108.5239574055768,GADD45A;MYC
8,KEGG_2021_Human,Small cell lung cancer,0.021739130434782608,0.0058614439271818,0.0377737497529494,0,0,19.21256038647343,98.7402509334194,GADD45A;MYC
